AI Drug Deals and Substance Use Breakthroughs
Kilder
- Statnews: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion - statnews.com
- Biospace: Common Pitfalls That Delay Regulatory Submissions, and How to Prevent Them - BioSpace
- Biospace: Lilly, Baseline Investigate GLP-1s’ Potential in Substance Use as Interest Mounts - BioSpace
- wikimedia: Photo by Paul Sableman / Wikimedia Commons / CC BY 2.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.